{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:52:34Z","timestamp":1787500354792,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.anai.2020.03.004","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T17:11:29Z","timestamp":1585588289000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A real-world assessment of asthma with chronic rhinosinusitis"],"prefix":"10.1016","volume":"125","author":[{"given":"Fabio Luigi Massimo","family":"Ricciardolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Elio","family":"Sprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitina","family":"Carriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Ciprandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.anai.2020.03.004_bib1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2014an underestimated disease. A GA2LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2020.03.004_bib2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis","volume":"136","author":"Bachert","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"issue":"suppl 1","key":"10.1016\/j.anai.2020.03.004_bib4","first-page":"S22","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.anai.2020.03.004_bib5","first-page":"183","article-title":"Staging in rhinosinusitis","volume":"31","author":"Lund","year":"1993","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0889-8561(03)00104-8","article-title":"Allergic rhinitis, rhinosinusitis, and asthma: one airway disease","volume":"24","author":"Bachert","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.anai.2020.03.004_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2500\/ajra.2011.25.3613","article-title":"Association between severity of asthma\u00a0and\u00a0degree of chronic rhinosinusitis","volume":"25","author":"Lin","year":"2011","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"10.1016\/j.anai.2020.03.004_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"suppl 2","key":"10.1016\/j.anai.2020.03.004_bib9","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1136\/thorax.55.suppl_2.S79","article-title":"Nasal polyposis, eosinophil dominated inflammation, and allergy","volume":"55","author":"Mygind","year":"2000","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.anai.2020.03.004_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1034\/j.1398-9995.2003.00110.x","article-title":"Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis","volume":"58","author":"Gevaert","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2020.03.004_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-9255-6-11","article-title":"Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue","volume":"6","author":"Patou","year":"2009","journal-title":"J\u00a0Inflamm (Lond)"},{"key":"10.1016\/j.anai.2020.03.004_bib12","author":"Timmerman"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2019.05.031","article-title":"Phenotypes and endotypes of adult asthma: moving toward precision medicine","volume":"144","author":"Kaur","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"143","key":"10.1016\/j.anai.2020.03.004_bib14","doi-asserted-by":"crossref","first-page":"160010","DOI":"10.1183\/16000617.0010-2016","article-title":"Personalised medicine in asthma: from curative to preventive medicine","volume":"26","author":"Guilleminault","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.anai.2020.03.004_bib15","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. GINA Guidelines. Available at: http:\/\/www.ginasthma.org\/. Accessed November 6, 2019."},{"issue":"2","key":"10.1016\/j.anai.2020.03.004_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.anai.2020.03.004_bib17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the Asthma Control Test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2004.01.016","article-title":"The natural history of allergy: the development of new sensitizations in asthmatic children","volume":"93","author":"Fasce","year":"2004","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1183\/13993003.01824-2014","article-title":"Asthma phenotypes and IgE responses","volume":"47","author":"Froidure","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib21","doi-asserted-by":"crossref","first-page":"00125","DOI":"10.1183\/23120541.00125-2017","article-title":"An algorithmic approach for the treatment of severe uncontrolled asthma","volume":"4","author":"Zervas","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.anai.2020.03.004_bib22","first-page":"691","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"5","year":"2015","journal-title":"Lancet Respir Med 2017"},{"issue":"5","key":"10.1016\/j.anai.2020.03.004_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jaci.2006.05.010","article-title":"The lower airway pathology of rhinitis","volume":"118","author":"Ciprandi","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2020.03.004_bib24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/all.13370","article-title":"Comorbid \u201ctreatable traits\u201d in difficult asthma: current evidence and clinical evaluation","volume":"73","author":"Tay","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2020.03.004_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12913-016-1562-8","article-title":"Is real-world evidence influencing practice? A systematic review of CPRD research in NICE guidances","volume":"16","author":"Oyinlola","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.anai.2020.03.004_bib26","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/13993003.00779-2015","article-title":"Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort","volume":"46","author":"Shaw","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2020.03.004_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fped.2019.00389","article-title":"Severe asthma-perspectives from adult and pediatric pulmonology","volume":"7","author":"Fleming","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.anai.2020.03.004_bib28","doi-asserted-by":"crossref","first-page":"154857","DOI":"10.1016\/j.cyto.2019.154857","article-title":"Increased type 2 inflammation post rhinovirus infection in patients with moderate asthma","volume":"125","author":"Southworth","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12890-019-0904-9","article-title":"Expression of eosinophil \u03b2 chain-signaling cytokines receptors, outer-membrane integrins, and type 2inflammation biomarkers in severe non-allergic eosinophilic asthma","volume":"19","author":"Kalinauskaite-Zukauske","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.anai.2020.03.004_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12931-019-1138-3","article-title":"Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis","volume":"20","author":"Edris","year":"2019","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.anai.2020.03.004_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2020.03.004_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2016.10.034","article-title":"Identification of IL-17F\/frequent exacerbator endotype in asthma","volume":"140","author":"Ricciardolo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2020.03.004_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11882-018-0776-8","article-title":"Precision medicine in chronic rhinosinusitis with nasal polyps","volume":"18","author":"Avdeeva","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"issue":"8","key":"10.1016\/j.anai.2020.03.004_bib34","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.waojou.2019.100050","article-title":"Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art","volume":"12","author":"Ren","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"2","key":"10.1016\/j.anai.2020.03.004_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11882-019-0850-x","article-title":"Precision medicine in rhinosinusitis","volume":"19","author":"Vlastos","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2020.03.004_bib36","first-page":"1","article-title":"Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice","volume":"9","author":"Price","year":"2016","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.anai.2020.03.004_bib37","series-title":"Use of real-world evidence to support regulatory decision-making for medical devices. Guidance for industry and Food and Drug Administration. Staff document issued on August 31, 2017","year":"2017"},{"issue":"23","key":"10.1016\/j.anai.2020.03.004_bib38","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence - what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.anai.2020.03.004_bib39","doi-asserted-by":"crossref","unstructured":"Le Floc'h A, Allinne J, Nagashima K, et\u00a0al. Dual blockade of IL-4 and IL-13 with\u00a0dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation [e-pub ahead of print]. Allergy. https:\/\/doi.org\/10.1111\/all.14151, Accessed December 31, 2019.","DOI":"10.1111\/all.14151"},{"issue":"2","key":"10.1016\/j.anai.2020.03.004_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/alr.22473","article-title":"The role of biologics in chronic rhinosinusitis: a systematic review","volume":"10","author":"Iqbal","year":"2020","journal-title":"Int Forum Allergy Rhinol"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620301484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620301484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:25:04Z","timestamp":1761053104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120620301484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1081120620301484"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2020.03.004","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A real-world assessment of asthma with chronic rhinosinusitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2020.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}